Empower your journey through cancer treatment decisions with our innovative Cancer Therapy Suitability test. This groundbreaking diagnostic assesses your healthy cells' DNA repair capabilities after exposure to treatments like radiotherapy or chemotherapy. Providing invaluable insights, the test allows patients to make informed decisions about the suitability of cancer treatments for their unique profile.
Facilities required: this tests can be performed in a clinic environment
Test time: Under 24 hours
Skill level required: Experienced lab technician
Rapid Species identification for Tuberculosis
Our advanced test designed identifies the Mycobacterium tuberculosis complex (MTBC) species that are causing infections. Tailored treatment choices are crucial, as different MTBC species demand varied therapeutic approaches. Our cutting-edge solution not only informs precise treatment decisions, fostering positive Antimicrobial Resistance (AMR) stewardship but also serves as a life-saving tool.
Facilities required: this tests can be performed in a mobile clinic environment
Unleash the precision of fungal infection treatment with our innovative test. Engineered specifically for respiratory infections caused by Aspergillus species, this groundbreaking diagnostic is designed to identify the exact species of fungi present, providing unparalleled insights for tailoring treatment plans with pinpoint accuracy. Say farewell to guesswork and welcome a new era of targeted fungal infection management. Revolutionise healthcare with our forthcoming fungi test, where accuracy meets innovation to save lives.
Facilities required: this tests can be performed in a clinic environment
Vidiia's COVID-19 test: pioneering rapid diagnostics, accredited and benchmarked as an exact alternative to PCR in the pandemic. Proven as sensitive and specific as PCR, it's a game-changer in swift, accurate testing.
